Infectious Disease

Infectious Disease includes companies developing antivirals, antibiotics, vaccines, and other programs aimed at preventing or treating viral, bacterial, or fungal infections. It is a broad category that can span both commercial public health products and early-stage pipeline assets.

Why watch Infectious Disease

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Infectious Disease news

The latest feed items from companies currently grouped under Infectious Disease.

1. 01
   2026-10-07 12:45 EST

   MBRXMoleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit

   Source: Moleculin Biotech, Inc.

2. 02
   2026-10-06 12:45 EST

   VIRIDogwood to Participate in the 2026 Maxim Growth Summit

   Source: Virios Therapeutics

3. 03
   2026-10-06 11:30 EST

   SCYXSCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

   Source: SCYNEXIS

4. 04
   2026-10-05 14:00 EST

   ASMBAssembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026

   Source: Assembly Biosciences

5. 05
   2026-10-02 21:05 EST

   SPROSpero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: Spero Therapeutics

6. 06
   2026-10-01 11:30 EST

   ABUSArbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

   Source: Arbutus

7. 07
   2026-09-30 11:30 EST

   ABUSArbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

   Source: Arbutus

8. 08
   2026-09-29 12:45 EST

   MBRXMoleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout

   Source: Moleculin Biotech, Inc.

9. 09
   2026-09-29 12:00 EST

   IMNNIMUNON Converts $1.2 Million of Debt-to-Equity

   Source: Imunon

10. 10
    2026-09-28 11:30 EST

    SCYXSCYNEXIS Awarded BARDA Contract Providing Up to $214 Million in Non-Dilutive Funding for the Development of SCY-247

    Source: SCYNEXIS

11. 11
    2026-09-28 11:00 EST

    ANTXAN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK

    Source: AN2 Therapeutics

12. 12
    2026-09-28 11:00 EST

    MBRXMoleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

    Source: Moleculin Biotech, Inc.

13. 13
    2026-09-25 17:05 EST

    MBRXAnnamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

    Source: Moleculin Biotech, Inc.

14. 14
    2026-09-24 12:05 EST

    IMNNIMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan

    Source: Imunon

15. 15
    2026-09-23 12:25 EST

    MBRXMoleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040

    Source: Moleculin Biotech, Inc.

16. 16
    2026-09-22 12:05 EST

    IMNNIMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review

    Source: Imunon

17. 17
    2026-09-22 12:00 EST

    SCYXSCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors

    Source: SCYNEXIS

18. 18
    2026-09-16 21:33 EST

    ANTXAN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)

    Source: AN2 Therapeutics

19. 19
    2026-09-15 12:00 EST

    SCYXSCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development

    Source: SCYNEXIS

20. 20
    2026-09-14 12:45 EST

    VIRIDogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial

    Source: Virios Therapeutics

Companies in Infectious Disease

30 companies tagged with Infectious Disease.

Frequently Asked Questions